By Ian Walker
LONDON--The soon-to-be-demerged pharmaceuticals unit of Reckitt
Benckiser Group PLC (RB.LN) has appointed Cary J. Claiborne as
Chief Financial Officer.
Reckitt Benckiser Pharmaceuticals, which is expected to be
called Indivior PLC when it lists on the London Stock Exchange this
year, said Mr. Claiborne was previously Chief Financial Officer of
Sucampo Pharmaceuticals Inc. (SCMP). He has also held senior
positions at New Generation Biofuels, Osiris Therapeutics,
Constellation Energy, Home Depot Corporation, MCI and General
Electric.
The consumer goods company, whose brands include Calgon, Finish,
Dettol and Durex, said in July that it planned to demerge the unit
and float it as a separately listed company, ending months of
speculation as to its fate. Last month, it said it expected this to
be completed this year,
Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
Subscribe to WSJ: http://online.wsj.com?mod=djnwires